This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sanguinetti, M. C. Search for Related Content PubMed PubMed Citation Articles by Sanguinetti, M. C.

Hypertension, Vol 19, 228-236, Copyright © 1992 by American Heart Association

ARTICLES

Modulation of potassium channels by antiarrhythmic and antihypertensive drugs

MC Sanguinetti
Department of Pharmacology, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486.

Agents that modulate cardiac and smooth muscle K+ channels have stimulated considerable interest in recent years because of their therapeutic potential in a number of cardiovascular diseases. Foremost among these drugs are the so-called Class III antiarrhythmic agents, which act by prolonging cardiac action potentials, and K+ channel openers, which hyperpolarize and thereby relax smooth muscle cells. Many of the newly developed Class III antiarrhythmic agents probably act by specific block of one subtype of delayed rectifier K+ current, IKr, whereas other agents block more than one type of cardiac K+ current. Much controversy exists over the specific type of K+ channel (or channels) in smooth muscle that are activated by the K+ channel openers. Both groups of K+ channel modulators have great therapeutic promise, but the Class III antiarrhythmic agents may suffer from a side- effect that is directly linked to their specific mechanism of action.

This article has been cited by other articles:

				J. A. W. Stecyk, V. Paajanen, A. P. Farrell, and M. Vornanen Effect of temperature and prolonged anoxia exposure on electrophysiological properties of the turtle (Trachemys scripta) heart Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R421 - R437. [Abstract] [Full Text] [PDF]

				C. Lerche, I. Bruhova, H. Lerche, K. Steinmeyer, A. D. Wei, N. Strutz-Seebohm, F. Lang, A. E. Busch, B. S. Zhorov, and G. Seebohm Chromanol 293B Binding in KCNQ1 (Kv7.1) Channels Involves Electrostatic Interactions with a Potassium Ion in the Selectivity Filter Mol. Pharmacol., June 1, 2007; 71(6): 1503 - 1511. [Abstract] [Full Text] [PDF]

				S. Ohya, K. Asakura, K. Muraki, M. Watanabe, and Y. Imaizumi Molecular and functional characterization of ERG, KCNQ, and KCNE subtypes in rat stomach smooth muscle Am J Physiol Gastrointest Liver Physiol, February 1, 2002; 282(2): G277 - G287. [Abstract] [Full Text] [PDF]

				I. C.-H. Yang, M. W. Scherz, A. Bahinski, P. B. Bennett, and K. T. Murray Stereoselective Interactions of the Enantiomers of Chromanol 293B with Human Voltage-Gated Potassium Channels J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 955 - 962. [Abstract] [Full Text]

				A. Emmi, H. J. Wenzel, P. A. Schwartzkroin, M. Taglialatela, P. Castaldo, L. Bianchi, J. Nerbonne, G. A. Robertson, and D. Janigro Do Glia Have Heart? Expression and Functional Role for Ether-A-Go-Go Currents in Hippocampal Astrocytes J. Neurosci., May 15, 2000; 20(10): 3915 - 3925. [Abstract] [Full Text] [PDF]

				C. E. Schotborgh and A. A.M. Wilde ATP-Sensitive Potassium Channel Openers and Blockers in the Cardiovascular System: Physiology, Pharmacology, and Clinical Effects Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 243 - 255. [Abstract] [PDF]

				M. K. Chung, R. A. Schweikert, B. L. Wilkoff, M. J. Niebauer, S. L. Pinski, R. G. Trohman, G. A. Kidwell, F. J. Jaeger, V. A. Morant, D. P. Miller, et al. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required?: yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications J. Am. Coll. Cardiol., July 1, 1998; 32(1): 169 - 176. [Abstract] [Full Text] [PDF]

				L. Eckardt, W. Haverkamp, M. Borggrefe, and G. Breithardt Experimental models of torsade de pointes Cardiovasc Res, July 1, 1998; 39(1): 178 - 193. [Abstract] [Full Text] [PDF]

				S. Vickers, C. A. Duncan, D. E. Slaughter, B. H. Arison, T. Greber, T. V. Olah, and K. P. Vyas Metabolism of MK-499, a Class III Antiarrhythmic Agent, in Rats and Dogs Drug Metab. Dispos., May 1, 1998; 26(5): 388 - 395. [Abstract] [Full Text]

				I. Kodama, K. Kamiya, and J. Toyama Cellular electropharmacology of amiodarone Cardiovasc Res, July 1, 1997; 35(1): 13 - 29. [Full Text] [PDF]

				C. Rodriguez-Sargent, E. S. Estape, N. Fernandez, J. E. Irizarry, J. L. Cangiano, and O. A. Candia Altered Lens Short-Circuit Current in Adult Cataract-Prone Dahl Hypertensive Rats Hypertension, September 1, 1996; 28(3): 440 - 443. [Abstract] [Full Text]

				S. G. Priori, C. Napolitano, F. Cantu, A. M. Brown, and P. J. Schwartz Differential Response to Na+ Channel Blockade, ß-Adrenergic Stimulation, and Rapid Pacing in a Cellular Model Mimicking the SCN5A and HERG Defects Present in the Long-QT Syndrome Circ. Res., June 1, 1996; 78(6): 1009 - 1015. [Abstract] [Full Text]

				M. R. Gralinski, L. Chi, J. L. Park, G. S. Friedrichs, E. J. Tanhehco, J. G. McCormack, and B. R. Lucchesi Protective Effects of Ranolazine on Ventricular Fibrillation Induced by Activation of the ATP-Dependent Potassium Channel in the Rabbit Heart Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 1996; 1(2): 141 - 148. [Abstract] [PDF]

				J. Kiehn, B. Wible, E. Ficker, M. Taglialatela, and A.M. Brown Cloned Human Inward Rectifier K+ Channel as a Target for Class III Methanesulfonanilides Circ. Res., December 1, 1995; 77(6): 1151 - 1155. [Abstract] [Full Text]

				S. H. Hohnloser and R. L. Woosley Sotalol N. Engl. J. Med., July 7, 1994; 331(1): 31 - 38. [Full Text]